Angiotensin II (Ang II)-induced astrocyte senescence may be involved in cerebral ischemic injury and age-associated neurodegenerative disease. This study was conducted to determine the roles of reactive oxygen species production in Ang II-induced cellular senescence in cultured human astrocytes. Human astrocytes were stimulated with Ang II either with or without an angiotensin type 1 receptor blocker, CV11974, or an antioxidant, tempol. Application of Ang II to human astrocytes resulted in a concentration-dependent increase in staining for dihydroethidium. Ang II (100 nM for 30 min) increased the translocation of two cytosolic components of NADPH oxidase, p47phox and p67phox, to the cell membrane and formation of the complex of p47phox, p67phox and p22phox. Ang II concentration-dependently induced an increase in b-galactosidase staining. Pretreatment with CV11974 (100 nM) or tempol (3 mM) abolished Ang II-induced astrocyte b-galactosidase staining. Moreover, Ang II significantly upregulated p16 mRNA expression, which was inhibited by pretreatment with CV11974 or tempol. These findings indicate that superoxide production contributes to Ang II-induced astrocyte senescence.
INTRODUCTION
It has been suggested that all components of the renin-angiotensin system exist in individual tissues, thus enabling the local synthesis, release and action of angiotensin II (Ang II). 1,2 The brain is a heterogeneous mixture of several cell types, including neurons and glial cells. Various components of renin-angiotensin system are expressed in glial and neural cells, suggesting a role for these cells in the central effects of Ang II. 3 In particular, astrocytes are the major source of angiotensinogen in the central nervous system. 4 Brain reninangiotensin system contributes to the regulation of blood pressure and water volume homeostasis through its effects on sympathetic outflow as well as vasopressin synthesis and release. 5 Aged astrocytes contain elevated levels of glial fibrillary acidic and S100b protein, 6 which are involved in the neuropathology of cerebral ischemia and Alzheimer's disease. 7 Recently, experimental and clinical studies have reported that cerebral ischemic injury and cognitive function can be ameliorated by inhibition of renin-angiotensin system. [8] [9] [10] Additionally, brain Ang II is upregulated both in cerebral ischemia and Alzheimer's disease and can be regulated with systemic angiotensin type 1 (AT1) receptor blocker (ARB) treatment. 9, 11, 12 Thus, Ang II-induced astrocyte senescence may be involved in the pathology of cerebral ischemic injury and age-associated neurodegenerative disease.
Superoxide and other reactive oxygen species (ROS) are recognized as important intracellular second messengers in a number of Ang II-mediated cellular processes. Cell senescence was originally described as the finite replicative lifespan of human somatic cells maintained in culture. Senescent cells enter irreversible growth arrest, exhibit a flattened and enlarged morphology and express senescence-related genes, such as p53/p21 and p16. These phenotypic changes have been implicated in aging and age-associated diseases. 13, 14 Recent reports have demonstrated that ROS mediate the activation of pathways that contribute to the pathogenesis of atherosclerosis (p53/p21 and p16 pathways) and initiate cellular senescence in vascular smooth muscle cells that are exposed to Ang II. 15, 16 In the brain, aged astrocytes exhibit a series of metabolic and morphological changes to become reactive astrocytes. These changes can be observed under a variety of conditions, including cerebral ischemia and Alzheimer's disease. 17 Furthermore, ROS has roles in the pathogenesis of aging and aging-associated neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. [18] [19] [20] Thus, astrocyte senescence and ROS production may have important roles in cerebral ischemia and in the development of ageassociated neurodegenerative diseases.
In this study, we hypothesized that Ang II has a direct effect on ROS generation through AT1 receptor-dependent activation of NADPH oxidase and that this interaction could contribute to Ang II-induced human astrocyte senescence. To test this hypothesis, we examined the effects of Ang II, ARB and an antioxidant on superoxide generation and cell senescence in cultured human astrocytes.
METHODS Reagents
Ang II, tempol and anti-b actin antibody were purchased from Sigma Chemical (St Louis, MO, USA). Dihydroethidium was obtained from Molecular Probes (Eugene, OR, USA). Anti-p47phox, -p67phox and -p22phox antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). CV11974 and ARB, were provided by Takeda Chemical Industries (Osaka, Japan).
Cell culture
All experimental procedures were performed according to the guidelines for the care and use of animals established by Kagawa University School of Medicine. Primary human brain astrocytes (ACBRI 371) were purchased from the Applied Cell Biology Research Institute (Kirkland, WA, USA) and were maintained in CS-C Medium Kits (Cell Systems, Kirkland, WA, USA). Characteristics of this primary human brain astrocytes were described previously. 21, 22 After stimulation, protein or mRNA was extracted as described previously. 9, 23 The protein concentration was determined using the Bradford assay kit (Bio-Rad Laboratories, Hercules, CA, USA).
Astrocytes were stimulated for 1 or 3 day(s) with Ang II at an appropriate final concentration, beginning on day 1. For the 7-days stimulation experiments, astrocytes were stimulated with Ang II on day 1, and medium was changed on day 3 with the same Ang II final concentration.
Senescence-associated b-galactosidase staining
Astrocytes were washed with phosphate-buffered solution and fixed in 4% paraformaldehyde in phosphate-buffered solution for 30 min. This was followed by three washes with phosphate-buffered solution. The degree of senescence in astrocyte cultures was evaluated using the senescence-associated b-galactosidase (SA b-gal) staining kit (Sigma Chemical) according to the manufacturer's instructions. Senescent astrocytes (stained blue) were observed with a microscope and digitally photographed.
Dihydroethidium staining
The oxidative fluorescence of dihydroethidium was used to evaluate intracellular O 2 À levels as described previously. 24 Briefly, human astrocytes were plated in a glass-bottom dish (Matsunami Glass Ind., Kishiwada, Japan) and allowed to adhere for at least 18 h. At the appropriate time after stimulation, dihydroethidium (5 mM) was added to the medium, and the incubation was continued for 15 min. Cells were then washed with phosphate-buffered solution, and images were obtained using a laser scanning confocal microscope system (Bio-Rad Laboratories). The average of fluorescence intensity values from 20 to 30 cells, taken from six different examinations, were calculated using ImageJ from the National Institutes of Health.
Real-time reverse transcriptase PCR
mRNA expression levels of p16 were analyzed by real-time reverse transcriptase PCR. All data were normalized against the expression of the glyceraldehyde-3-phosphate dehydrogenase gene. The sense and antisense sequences for p16 were 5¢-GGAAGCTGTCGACTTCATGACA-3¢ and 5¢-GAGCTTTGGTTCTGCCATT TG-3¢, respectively.
NADPH oxidase complex formation
NADPH oxidase complex formation was assessed by immunoprecipitation/ western blotting as previously described. 25 Quiescent astrocytes treated with Ang II for 30 min were lysed in cold lysis buffer consisting of 20 mM Tris-HCl, pH 7.4, 140 mM NaCl, 1% Triton-X, 10% glycerol, 1mM b-glycerophosphate, 1 mM sodium orthovanadate and complete protease inhibitor tablet (Roche, Mannheim, Germany; 1 tablet per 25 ml buffer). The homogenates were then subjected to sonication for 10 s on ice (repeated three times), followed by centrifugation for 30 min at 12 000 g to remove cellular debris. The same amount of protein (100 mg) was incubated with 4 mg of polyclonal anti-p22phox overnight at 41C. The resulting immune complexes were precipitated by incubation with protein-A/G sepharose for a further 2 h at 4 1C. After they had been washed twice, the pellets were resuspended in 2Â Laemmli sample buffer, boiled for 5 min, and subjected to SDS-polyacrylamide gel electrophoresis following semidry transfer to polyvinylidene difluoride membranes, the membranes were probed with p47phox, p67phox and p22phox antibodies overnight at 4 1C, before being incubated for 1 h with a secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG, 1:2000). Immunoreactive bands were visualized using enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA) and quantified by densitometry in the linear range of film exposure using LAS-1000 plus (FUJIFILM Co., Tokyo, Japan).
Statistical analyses
The values are presented as mean ± s.d. One-way analysis of variance was used to determine significant differences among groups. When the overall analysis of variance P-value was o0.05, Bonferroni's correction for multiple comparisons was used to assess individual group differences. Po0.05 was considered statistically significant.
RESULTS

Effect of Ang II on astrocyte senescence
Senescence characteristics in astrocyte cultures were evaluated using SA b-gal staining. Figure 1a shows the time course of Ang II-induced increases in SA b-gal-positive cells (n¼12 for each). After treatment with Ang II (100 nM) for 3 or 7 days, the number of SA b-gal-positive cells was significantly higher than in the control group (Po0.01). 
Effect of Ang II on O 2
À production To determine whether Ang II stimulates ROS production in human astrocytes, intracellular O 2 À level was evaluated with dihydroethidium staining. Figure 2a shows the time course of Ang II-induced increases in dihydroethidium staining (n¼6 for each). Ang II-induced (100 nM) increases in dihydroethidium staining peaked at 30 min. Figure 2b shows the concentration-dependent effects of Ang II (30 min) on dihydroethidium staining (n¼6 for each). Moreover, pretreatment with CV11974 (100 nM) for 3 h significantly attenuated the Ang II-induced (1000 nM) increases in dihydroethidium staining. Representative results of dihydroethidium staining are shown in Figure 2b .
Effect of Ang II on NADPH oxidase complex formation Activation of NADPH oxidase requires translocation of its cytosolic components, p47phox and p67phox, to the cell membrane and formation of a complex between p47phox, p67phox and p22phox. Therefore, we examined the effects of Ang II on the complex formation of p47phox, p67phox and p22phox in astrocytes by immunoprecipitation/western blotting analysis. As shown in Figure 3 , Ang II induced complex formation of NADPH oxidase in a concentration-dependent manner. Additionally, pretreatment with CV11974 (100 nM) significantly attenuated Ang II-induced (1000 nM) complex formation (n¼4 for each). As a control for the immunoprecipitations, the amounts of p47phox, p67phox and p22phox precipitated in each group were determined through direct immunoblotting; the levels of these components in each group were essentially constant (data not shown).
Effects of CV11974 and tempol on Ang II-induced astrocyte senescence To investigate the role of AT1 receptor and O 2 À production in Ang IIinduced astrocyte senescence, the effects of CV11974 (an AT1 receptor blocker) and tempol (a superoxide dismutase mimetic) on the number of SA b-gal-positive cells were examined (n¼6 for each). Before incubation with Ang II (100 nM), astrocytes were pretreated with either CV11974 (100 nM) for 3 h or tempol (3 mM) for 30 min. As shown in Figure 4b , CV11974 significantly inhibited the Ang IIinduced increase in the number of SA b-gal-positive cells (Po0.01). In addition, the Ang II-induced increase in SA b-gal-positive cells was attenuated after preincubation with tempol (Po0.01). Representative results of the b-galactosidase staining are shown in Figure 4 . These results suggest that Ang II induces astrocyte senescence through an O 2 À production-dependent pathway that involves the AT1 receptor.
Effect of Ang II on p16 mRNA expression
To further investigate the mechanism of Ang II-induced astrocyte senescence, the expression of p16 mRNA was examined. As shown in Figure 5 , after 3-days treatment with Ang II (100 nM), p16 mRNA expression was significantly higher than in the control group (n¼6 for each, Po0.05). Moreover, CV11974 (100 nM) and tempol (3 mM) significantly blocked Ang II-induced increases in p16 mRNA expression. This suggests that p16 may be involved in Ang II-induced astrocyte senescence.
DISCUSSION
This study shows that Ang II directly induced superoxide production in human astrocytes and that this mechanism contributed to Ang IIinduced astrocyte senescence. In addition, these effects of Ang II were inhibited by pretreatment with the ARB CV11974. This suggests that the AT1 receptor may have a role in mediating these effects of Ang II. A signaling mechanism for Ang II that involves superoxide and other ROS has been identified in peripheral tissues. Ang II stimulates ROS generation and activates molecules associated with redox regulation in the vasculature, 26 heart 27 and kidney. 2 In addition, superoxide mediates the actions of Ang II in the central nervous system, including in its regulation of blood pressure, heart rate and drinking behavior. 28 Moreover, NADPH oxidase inhibition attenuates the neuronal chronotropic actions of Ang II. 29 To the best of our knowledge, this study is the first to demonstrate that Ang II stimulates AT1-dependent dihydroethidium fluorescence in human astrocytes. Furthermore, the Ang II-induced production of superoxide was abolished by pretreatment with ARB.
NADPH oxidase is composed of membrane-associated components (gp91phox and p22phox) and cytosolic regulatory subunits (p40phox, p47phox, p67phox and Rac). 30 Activation of NADPH oxidase requires translocation of the cytosolic components to the cell membrane. Our study shows that Ang II directly induces both the translocation of p47phox and p67phox to the astrocyte membrane and the binding of p22phox to them. Moreover, the time courses of Ang II-induced superoxide production and membranous translocation of p47phox and p67phox were similar. Pretreatment with ARB abolished not only superoxide production but also the translocation of p47phox and p67phox to the membrane. Thus, these data are consistent with the concept that membranous translocation of p47phox and p67phox is involved, at least in part, in the overall elevation in superoxide production in human astrocytes. This study also indicated the potential contribution of the AT1 receptor to these effects of Ang II in human astrocytes.
The tumor suppressor proteins p53 and pRb regulate two pathways that contribute to the establishment and maintenance of cellular senescence. 14 Both proteins are transcriptional regulators, and they are crucially involved in signaling pathways that are responsible for cell cycle regulation, DNA repair and cell death. 31 Recent studies have indicated that Ang II induces cell senescence through a p53/p21-dependent pathway in vascular smooth muscle cells and endothelial cells. 15, 32 Moreover, Min et al. 16 have also reported that p16 is involved in Ang II-induced vascular smooth muscle cell senescence. p16 is a positive regulator of pRb that is induced by a variety of stress stimuli, including Ang II. 16, 33 Furthermore, ROS mediate the activation of p53/p21 and p16 pathways as well as cellular senescence induced by Ang II. 15, 16 In this study, we found that Ang II upregulated p16 mRNA expression but not p53 or p21 expression (data not shown). Pretreatment with ARB or tempol attenuated Ang II-induced upregulation of p16. This suggests that p16 might be involved in Ang II-induced human astrocyte senescence.
It will be important to explain how astrocyte senescence, which we observed under Ang II stimulation, is involved in pathological conditions. Several reports have evaluated the functional changes that occur in senescent astrocytes. Similar to activated astrocytes, senescent astrocytes lose their neuroprotective function and show increased expression of glial fibrillary acidic protein and S100b. 34 However, to our knowledge, no study has evaluated SA b-gal expression in astrocytes in vivo. As neurodegenerative diseases progress slowly, Ang II-induced astrocyte senescence may not be the only mechanism underlying neurodegenerative disease. In our experimental cerebral ischemia rat model, rat brain Ang II content increases following Ang II + Tempol (n=6) p16/GAPDH mRNA expression * † † Figure 5 Effects of CV11974 and tempol on Ang II (100 nM, 3 days)-induced p16 mRNA expression in human astrocytes. All data were normalized against GAPDH mRNA and the ratio to the control is shown. *Po0.05 vs. control, w Po0.01 vs. Ang II (100 nM).
reperfusion, but at around 50 fmol g À1 tissue, it is still approximately 1/2000 of the in vitro level (100 nM¼100 pmol ml À1 ) used in this study. 9, 12 Even in plasma, Ang II content (around 150 pM¼ 150 fmol ml À1 ) in those rats is also around 1/600 of the in vitro condition used in this study. 12 Therefore, we believe it is not easy to be similar Ang II stimulation conditions under in vivo cerebral ischemia to in vitro Ang II stimulation made in this study. Additionally, there may also exist systemic counter-action mechanisms against Ang II-stimulated astrocyte senescence. Our results suggest that systemic superoxide dismutase or NADPH oxidase inhibitors can assist these counter-action mechanisms against Ang II-stimulated astrocyte senescence.
Ischemic or hemorrhagic strokes can have a number of neurological consequences, including cognitive impairment and the eventual development of dementia. 35 In addition to its effect on cerebral ischemia, treatment with ARB may improve cognitive function and dementia. The Study on Cognition and Prognosis in the Elderly has reported that antihypertensive therapy with the ARB candesartan prevents the decline of cognitive function and reduces the incidence of dementia in elderly nondemented patients. 8 Recent reports have also demonstrated that valsartan improves Alzheimer's disease through mechanisms that affect b-amyloid protein neuropathology, but are independent of blood pressure-lowering activity. 36 Thus, Ang II-induced astrocyte senescence may be involved in cerebral ischemic injury and age-associated neurodegenerative diseases.
In summary, this study demonstrates that Ang II directly induces astrocyte senescence through a superoxide production-dependent mechanism. Ang II-induced superoxide production may result, at least in part, from membranous translocation of p47phox and p67phox. Our data also indicate a role for the AT1 receptor in the Ang II-mediated production of superoxide anions and astrocyte senescence. These findings provide novel insights into the mechanisms responsible for Ang IIinduced ROS production during the progression of cerebral ischemic injury and age-associated neurodegenerative diseases.
